- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06701773
Computational Fluid Dynamics Predicting Intraprosthetic Thrombus Formation and Progression Following EVAR
November 20, 2024 updated by: Wei Wang, Xiangya Hospital of Central South University
Computational Fluid Dynamics Predicting Intraprosthetic Thrombus Formation and Progression Following Endovascular Aortic Repair: a Two-center Retrospective Study
Intraprosthetic thrombus (IPT) formation and its progression to limb graft occlusion (LGO) are significant complications following endovascular aneurysm repair (EVAR).
Morphological metrics based on preoperative CTA have limited predictive value for these complications.
This study aims to assess the potential of computational fluid dynamics (CFD) in predicting IPT formation and its progression to LGO after EVAR.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
72
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Probability Sample
Study Population
Patients undergone endovascular aneurysm repair.
Description
Inclusion Criteria:
- Aged 18 and above;
- Patients undergone endovascular aneurysm repair;
- Signed informed consent forms, willing to receive treatments.
Exclusion Criteria:
- inflammatory aortic aneurysm;
- patients diagnosed with connective tissue diseases;
- patients diagnosed with atrial fibrillation;
- patients lacking post-operative CTA;
- Patients who are participating in other clinical projects;
- Patients are not suitable to participate in this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Intraprosthetic thrombus Group
presence of intraprosthetic thrombus according to the postoperative CTA
|
|
Non-intraprosthetic thrombus Group
absence of intraprosthetic thrombus according to the postoperative CTA
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Degree of intraprosthetic thrombus in limb graft
Time Frame: From January 2014 to June 2024
|
Evaluate the area of thrombus occupying the lumen using postoperative CTA
|
From January 2014 to June 2024
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Disease-related complications
Time Frame: From January 2014 to June 2024
|
Disease-related complications associated with intraprosthetic thrombus or limb graft occlusion, such as thromboembolic events
|
From January 2014 to June 2024
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2014
Primary Completion (Actual)
June 30, 2024
Study Completion (Actual)
June 30, 2024
Study Registration Dates
First Submitted
November 17, 2024
First Submitted That Met QC Criteria
November 20, 2024
First Posted (Estimated)
November 22, 2024
Study Record Updates
Last Update Posted (Estimated)
November 22, 2024
Last Update Submitted That Met QC Criteria
November 20, 2024
Last Verified
November 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2024030373
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intraprosthetic Thrombus
-
Medical University of ViennaUnknownThrombosis | Thrombus Formation | Thrombus StabilityAustria
-
China National Center for Cardiovascular DiseasesRecruitingVentricular ThrombusChina
-
Centro Cardiologico MonzinoFondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoRecruiting
-
Queen Mary University of LondonRecruiting
-
Peshawar Institute of CardiologyGetz PharmaRecruitingLeft Ventricular ThrombusPakistan
-
Fudan UniversityRecruiting
-
University of LimerickCompleted
-
Ottawa Heart Institute Research CorporationWithdrawn
-
Saud Al Babtain Cardiac CenterCompleted
-
Centre Hospitalier Universitaire de NīmesCompletedStroke | Intracardiac ThrombusFrance